{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:27:37Z","timestamp":1792301257921,"version":"4.4.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220450","type":"journal-article","created":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T13:29:29Z","timestamp":1564493369000},"page":"e0220450","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Do early luteal serum progesterone levels predict the reproductive outcomes in IVF with oral dydrogesterone for luteal phase support?"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-0800","authenticated-orcid":true,"given":"Antoine","family":"Netter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9500-8598","authenticated-orcid":true,"given":"Julien","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Buffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubert","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Courbiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12958-016-0225-2","article-title":"Systematic review of worldwide trends in assisted reproductive technology 2004\u20132013","volume":"15","author":"VA Kushnir","year":"2017","journal-title":"Reprod Biol Endocrinol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.rbmo.2014.01.012","article-title":"Improving the luteal phase after ovarian stimulation: reviewing new options","volume":"28","author":"C Yding Andersen","year":"2014","journal-title":"Reproductive BioMedicine Online"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/molehr\/8.9.871","article-title":"Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening","volume":"8","author":"DD Carson","year":"2002","journal-title":"Molecular Human Reproduction"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mce.2011.10.028","article-title":"The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network","volume":"357","author":"M Wetendorf","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","volume":"87","author":"BC Fauser","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.rbmo.2018.02.001","article-title":"Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles","volume":"36","author":"T Child","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"ref7","article-title":"Luteal phase support for assisted reproduction cycles","author":"M van der Linden","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/humrep\/dex316","article-title":"Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study","volume":"32","author":"E Labarta","year":"2017","journal-title":"Hum Reprod"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.rbmo.2015.05.005","article-title":"Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement","volume":"31","author":"JL Yovich","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.rbmo.2018.08.022","article-title":"Progesterone levels on pregnancy test day after hormone replacement therapy-cryopreserved embryo transfer cycles and related reproductive outcomes","volume":"37","author":"B Alsbjerg","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"ref11","article-title":"The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602","author":"LH Thomsen","year":"2018","journal-title":"IVF\/ICSI cycles. Hum Reprod"},{"key":"ref12","first-page":"2312","article-title":"Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence?","volume":"33","author":"CA Venetis","year":"2018","journal-title":"Hum Reprod"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/humrep\/dex023","article-title":"A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization","volume":"32","author":"H Tournaye","year":"2017","journal-title":"Hum Reprod"},{"key":"ref14","article-title":"film-coated tablets 10 mg Summary of Product Characteristics","author":"B.V. Abbott","year":"2017","journal-title":"film-coated tablets 10 mg Summary of Product Characteristics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.fertnstert.2018.03.034","article-title":"Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?","volume":"109","author":"G Griesinger","year":"2018","journal-title":"Fertil Steril"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rbmo.2018.11.017","article-title":"Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction","volume":"38","author":"G Griesinger","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2005.08.012","article-title":"Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study","volume":"97","author":"BN Chakravarty","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 1","key":"ref18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/09513590701584857","article-title":"Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone","volume":"23","author":"A Patki","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.fertnstert.2011.01.148","article-title":"Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study","volume":"95","author":"A Ganesh","year":"2011","journal-title":"Fertil Steril"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejogrb.2014.11.002","article-title":"Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial","volume":"186","author":"V Tomic","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/09513590.2015.1110136","article-title":"A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles","volume":"32","author":"N Saharkhiz","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1365\/s10337-006-0035-3","article-title":"Determination of Dydrogesterone in Human Plasma by Tandem Mass Spectrometry: Application to Therapeutic Drug Monitoring of Dydrogesterone in Gynecological Disorders","volume":"64","author":"ME Abdel-Hamid","year":"2006","journal-title":"Chroma"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2017.06.017","article-title":"Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization\/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation","volume":"108","author":"X Zhu","year":"2017","journal-title":"Fertil Steril"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"S Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/86.11.829","article-title":"Dangers of using \u201coptimal\u201d cutpoints in the evaluation of prognostic factors","volume":"86","author":"DG Altman","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.fertnstert.2018.04.037","article-title":"Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients","volume":"109","author":"BW Mol","year":"2018","journal-title":"Fertil Steril"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2013-3937","article-title":"Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert","volume":"99","author":"RJ Paulson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref28","first-page":"403","article-title":"Direct transport of progesterone from vagina to uterus","volume":"95","author":"E Cicinelli","year":"2000","journal-title":"Obstet Gynecol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0015-0282(97)00457-3","article-title":"Experience with a novel vaginal progesterone preparation in a donor oocyte program","volume":"69","author":"WE Gibbons","year":"1998","journal-title":"Fertil Steril"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0220450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:01:43Z","timestamp":1588960903000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220450"}},"subtitle":[],"editor":[{"given":"Dragana","family":"Nikitovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220450","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]}}}